Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Plus Therapeutics (PSTV) Return on Sales (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Return on Sales for 15 consecutive years, with 4.18% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 142.0% to 4.18% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 3.02% through Dec 2025, down 51.0% year-over-year, with the annual reading at 3.02% for FY2025, 51.0% down from the prior year.
  • Return on Sales for Q4 2025 was 4.18% at Plus Therapeutics, down from 3.17% in the prior quarter.
  • The five-year high for Return on Sales was 34.59% in Q2 2022, with the low at 71.86% in Q3 2022.
  • Average Return on Sales over 5 years is 3.13%, with a median of 2.6% recorded in 2024.
  • The sharpest move saw Return on Sales tumbled -8792bps in 2022, then soared 7113bps in 2023.
  • Over 5 years, Return on Sales stood at 16.06% in 2021, then plummeted by -375bps to 44.17% in 2022, then skyrocketed by 93bps to 2.9% in 2023, then rose by 5bps to 2.76% in 2024, then plummeted by -51bps to 4.18% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 4.18%, 3.17%, and 1.09% for Q4 2025, Q3 2025, and Q2 2025 respectively.